Dimensional Fund Advisors’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEM
Dimensional Fund Advisors's CGEM Position: Q3 2026 in Review
Dimensional Fund Advisors increased its Cullinan Oncology (CGEM) stake by 3.6% in Q3 2026, buying an estimated $729K and bringing the position to 1,084,765 shares worth $16.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2098.
Dimensional Fund Advisors first reported a position in CGEM in Q3 2022 and has held it in 16 quarters since. The position peaked at $19.1M in Q2 2026. 55 funds tracked by Wall St. Rank hold CGEM as of Q3 2026.
- Dimensional Fund Advisors held 1,084,765 shares of Cullinan Oncology worth $16.7M as of Q3 2026.
- Dimensional Fund Advisors bought 38,071 Cullinan Oncology shares in Q3 2026, an estimated $729K.
- Cullinan Oncology made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2098 holding.
- Dimensional Fund Advisors first reported a position in Cullinan Oncology in Q3 2022 and has held it in 16 quarters since.
- Dimensional Fund Advisors's Cullinan Oncology position peaked at $19.1M in Q2 2026.
- 55 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2026.
Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.